I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Clinical experience with the AKT1 inhibitor miransertib in ..:
Forde, Karina
;
Resta, Nicoletta
;
Ranieri, Carlotta
...
https://www.repository.cam.ac.uk/handle/1810/318219. , 2021
Link:
https://www.repository.cam.ac.uk/handle/1810/318219
RT Journal T1
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
UL https://suche.suub.uni-bremen.de/peid=base-ftunivcam:oai:www.repository.cam.ac.uk:1810_318219&Exemplar=1&LAN=DE A1 Forde, Karina A1 Resta, Nicoletta A1 Ranieri, Carlotta A1 Rea, David A1 Kubassova, Olga A1 Hinton, Mark A1 Andrews, Katrina A A1 Semple, Robert A1 Irvine, Alan D A1 Dvorakova, Veronika PB Springer Science and Business Media LLC; http://dx.doi.org/10.1186/s13023-021-01745-0; Orphanet J Rare Dis YR 2021 K1 AKT inhibitor K1 Miransertib K1 Next generation sequencing (NGS) K1 PIK3CA-related overgrowth spectrum (PROS) K1 Targeted treatment K1 Aminopyridines K1 Child K1 Class I Phosphatidylinositol 3-Kinases K1 Humans K1 Imidazoles K1 Mutation K1 Phosphatidylinositol 3-Kinases K1 Proto-Oncogene Proteins c-akt K1 Quality of Life JF https://www.repository.cam.ac.uk/handle/1810/318219 LK http://dx.doi.org/https://www.repository.cam.ac.uk/handle/1810/318219 DO https://www.repository.cam.ac.uk/handle/1810/318219 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)